Brain Imaging Changes and Related Risk Factors of Cognitive Impairment in Patients With Heart Failure

• Published in: Frontiers in cardiovascular medicine Vol. 8; p. 838680
• Main Authors: Jiang, Yangyang, Wang, Lei, Lu, Ziwen, Chen, Shiqi, Teng, Yu, Li, Tong, Li, Yang, Xie, Yingzhen, Zhao, Mingjing
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 26-01-2022
• Subjects: brain imaging; Cardiovascular Medicine; cognitive impairment; heart failure; risk factors; systematic review; brain imaging; heart failure; risk factors; cognitive impairment; systematic review
• ISSN: 2297-055X; 2297-055X
• DOI: 10.3389/fcvm.2021.838680

To explore the imaging changes and related risk factors of heart failure (HF) patients with cognitive impairment (CI).
A literature search was systematically carried out in PubMed, Web of Science, Embase, and Cochrane Library. In this systematic review, important relevant information was extracted according to the inclusion and exclusion criteria. The methodological quality was assessed by three scales according to the different study types.
Finally, 66 studies were included, involving 33,579 patients. In the imaging changes, the severity of medial temporal lobe atrophy (MTA) and the decrease of gray Matter (GM) volume were closely related to the cognitive decline. The reduction of cerebral blood flow (CBF) may be correlated with CI. However, the change of white matter (WM) volume was possibly independent of CI in HF patients. Specific risk factors were analyzed, and the data indicated that the increased levels of B-type natriuretic peptide (BNP)/N-terminal pro-B-type natriuretic peptide (NT-proBNP), and the comorbidities of HF, including atrial fibrillation (AF), diabetes mellitus (DM) and anemia were definitely correlated with CI in patients with HF, respectively. Certain studies had also obtained independent correlation results. Body mass index (BMI), depression and sleep disorder exhibited a tendency to be associated with CI. Low ejection fraction (EF) value (<30%) was inclined to be associated with the decline in cognitive function. However, no significant differences were noted between heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF) in cognitive scores.
BNP/NT-proBNP and the comorbidities of HF including AF, DM and anemia were inextricably correlated with CI in patients with HF, respectively. These parameters were independent factors. The severity of MTA, GM volume, BMI index, depression, sleep disorder, and low EF value (<30%) have a disposition to associated with CI. The reduction in the CBF volume may be related to CI, whereas the WM volume may not be associated with CI in HF patients. The present systematic review provides an important basis for the prevention and treatment of CI following HF.